Microsoft Builds Relationships in Synthetic Biology


By Kevin Davies

Microsoft Research (MSR) has launched a new funding initiative in the promising but controversial field of computational challenges in synthetic biology.

Unlike the BioIT Alliance, through which Microsoft encourages links with industrial partners to create solutions in the life sciences, the principal aim of MSR is to forge partnerships with academic researchers. The new request for proposals (RFP) allocates $500,000 for two principle areas of synthetic biology research:

  1. The re-engineering of natural biological pathways to produce interoperable, composable, standard biological parts. Examples include the role of computers in the “specification, simulation, construction and dissemination of biological components or systems of interacting components.”
  2. Tools and information repositories relating to the use of DNA in the fabrication of nanostructures and nanodevices.

According to bioinformatics program manager Simon Mercer, MSR is trying to build relationships with the academic community “in a range of areas of strategic interest. These range from pen-centric computing to robotics and from computing in emerging economies to addressing the shortage of undergraduates enrolling in computer science.”

Mercer says that the challenges faced by scientists today will be faced by business tomorrow and eventually by everyone. “Encouraging and participating in basic research helps us to better understand these problems and their potential solutions,” says Redmond, Wash.-based Mercer. “We believe we already have products and technologies that can help scientists work more efficiently, or which may form the basis for new applications that could help advance the state of the art in research.”

Synthetic biology is a particularly interesting field, Mercer asserts, because it has “the potential to provide insights into living systems, transform biotechnology and perhaps generate entirely new industries. We might be able to help this happen.”

Microsoft will announce the synthetic biology award winners next March, encouraging proposals that utilize or integrate other funding sources and resources such as the MIT BioBricks repository. Software and data are to be made freely available to the scientific community.

Related stories:
Microsoft Forges BioIT Alliance

Synthetic Biologists Assemble Codon Devices Company

Subscribe to Bio-IT World  magazine.

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.